Sinopharm
1099.HK
#1953
Rank
โ‚น696.00 B
Marketcap
โ‚น223.03
Share price
-3.52%
Change (1 day)
6.64%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Revenue for Sinopharm (1099.HK)

Revenue in 2023 (TTM): โ‚น5.089 Trillion

According to Sinopharm's latest financial reports the company's current revenue (TTM ) is โ‚น6.762 Trillion. In 2022 the company made a revenue of โ‚น6.762 Trillion a decrease over the revenue in the year 2021 that were of โ‚น6.907 Trillion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Sinopharm from 2006 to 2023

Annual revenue

Year Revenue Change
2023 (TTM) โ‚น5.089 T-24.74%
2022 โ‚น6.762 T-2.1%
2021โ‚น6.907 T16.85%
2020โ‚น5.911 T14.95%
2019โ‚น5.142 T21.52%
2018โ‚น4.231 T5.93%
2017โ‚น3.994 T27.22%
2016โ‚น3.139 T5.37%
2015โ‚น2.979 T9.14%
2014โ‚น2.730 T17.22%
2013โ‚น2.329 T25.94%
2012โ‚น1.849 T34.61%
2011โ‚น1.373 T55.34%
2010โ‚น884.42 B35.79%
2009โ‚น651.32 B37.56%
2008โ‚น473.49 B31.43%
2007โ‚น360.27 B40.26%
2006โ‚น256.85 B